{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"overgrowth-syndrome-and-or-cerebral-malformations-due-to-abnormalities-in-mtor-pathway-genes","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A disease caused by mosaic gain-of-function (GoF) of several genes in the MTOR pathway (MTOR, PIK3CA, PIK3R2 and AKT3) are functionally the same despite significant phenotypic variability. These GoF variants result in overgrowth due to an over-activation of key genes in this pathway. The phenotypic variability is generally attributed to the mosaic fraction and affected tissue types. For example, macrocephaly is noted if the variant is identified in the brain, but non symmetric overgrowth of that limb is noted when the variant is only present in the affected limb. The pathologies of the affected tissue often reveal similar characteristics such as cellular overgrowth. However, this is not always the case especially with focal cortical dysplasia. At times the characteristics pathologies are not present in the tissue but sampling biases are an issue. FCD resections often involve a very small area and so a very small amount of tissue is available for pathology and it is not guaranteed that lesional tissue is sent. Therefore, having a single disease term which can encompass the phenotypic variability yet provide a unifying molecular diagnosis name makes sense given the common functional mechanism.","mondoId":"MONDO:0100283","node":{"canonicalSlug":"overgrowth-syndrome-and-or-cerebral-malformations-due-to-abnormalities-in-mtor-pathway-genes","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes","paragraphs":["A disease caused by mosaic gain-of-function (GoF) of several genes in the MTOR pathway (MTOR, PIK3CA, PIK3R2 and AKT3) are functionally the same despite significant phenotypic variability. These GoF variants result in overgrowth due to an over-activation of key genes in this pathway. The phenotypic variability is generally attributed to the mosaic fraction and affected tissue types. For example, macrocephaly is noted if the variant is identified in the brain, but non symmetric overgrowth of that limb is noted when the variant is only present in the affected limb. The pathologies of the affected tissue often reveal similar characteristics such as cellular overgrowth. However, this is not always the case especially with focal cortical dysplasia. At times the characteristics pathologies are not present in the tissue but sampling biases are an issue. FCD resections often involve a very small area and so a very small amount of tissue is available for pathology and it is not guaranteed that lesional tissue is sent. Therefore, having a single disease term which can encompass the phenotypic variability yet provide a unifying molecular diagnosis name makes sense given the common functional mechanism."],"scope":"exact","source":"MONDO","upstream":"https://clinicalgenome.org/affiliation/40020/, PMID:22729223, PMID:27860216, PMID:30349109","url":"https://monarchinitiative.org/MONDO:0100283"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"central nervous system malformation","mondoId":"MONDO:0020022","slug":null},{"kind":"child","label":"megalencephaly-capillary malformation-polymicrogyria syndrome","mondoId":"MONDO:0011240","slug":"megalencephaly-capillary-malformation"},{"kind":"child","label":"macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome","mondoId":"MONDO:0014716","slug":"smith-kingsmore"},{"kind":"child","label":"isolated focal cortical dysplasia","mondoId":"MONDO:0019009","slug":"isolated-focal-cortical-dysplasia"},{"kind":"child","label":"megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome","mondoId":"MONDO:0019375","slug":"megalencephaly-polymicrogyria-polydactyly-hydrocephalus"},{"kind":"child","label":"hemimegalencephaly","mondoId":"MONDO:0020492","slug":"hemimegalencephaly"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26123"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100283\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://clinicalgenome.org/affiliation/40020/, PMID:22729223, PMID:27860216, PMID:30349109</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A disease caused by mosaic gain-of-function (GoF) of several genes in the MTOR pathway (MTOR, PIK3CA, PIK3R2 and AKT3) are functionally the same despite significant phenotypic variability. These GoF variants result in overgrowth due to an over-activation of key genes in this pathway. The phenotypic variability is generally attributed to the mosaic fraction and affected tissue types. For example, macrocephaly is noted if the variant is identified in the brain, but non symmetric overgrowth of that limb is noted when the variant is only present in the affected limb. The pathologies of the affected tissue often reveal similar characteristics such as cellular overgrowth. However, this is not always the case especially with focal cortical dysplasia. At times the characteristics pathologies are not present in the tissue but sampling biases are an issue. FCD resections often involve a very small area and so a very small amount of tissue is available for pathology and it is not guaranteed that lesional tissue is sent. Therefore, having a single disease term which can encompass the phenotypic variability yet provide a unifying molecular diagnosis name makes sense given the common functional mechanism.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100283\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"overgrowth-syndrome-and-or-cerebral-malformations-due-to-abnormalities-in-mtor-pathway-genes","sourceDocuments":[{"name":"MONDO: overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0100283"}],"sourceNote":"","synonyms":["overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes"],"takeawayHtml":"","title":"overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes"},"schemaVersion":1}
